Diabetes Symposium | Continuing Medical Education | CME, Medical Conference - Baptist Health
Skip Ribbon Commands Skip to main content
 
_________
Diabetes Symposium
For more information please visit
BaptistHealth.net/CME
_____________________
Register

Educational Objectives________________

    Erectile Dysfunction in Diabetic Men
    Upon completion of this session, participants should be better able to:
    • Define PDE5 inhibitor failure in the diabetic patient.
    • Utilize clinical principles and expert opinions to evaluate patients with erectile dysfunction.
    • Describe the surgical treatment options for men with erectile dysfunction.

    Advances in the Management of Diabetes in the Hospital Setting: Use of Oral Agents
    Upon completion of this session, participants should be better able to:
    • Develop a consistent approach to initiating insulin in the hospital.
    • Appropriately adjust insulin therapy to accommodate special situations for hospitalized patients with hyperglycemia.

    The Diabetic Heart
    Upon completion of this session, participants should be better able to:
    • Describe the mechanism of action by which diabetes mellitus (DM) can cause atherosclerotic coronary artery disease.
    • Explain the association between DM, cardiovascular disease (CVD) and A1C levels.
    • Discuss the relationship between DM and diabetic cardiomyopathy.
    • Describe the mechanisms linking DM, obesity and CVD.
     
    Diabetic Nephropathy
    Upon completion of this session, participants should be better able to:
    • Describe the prevalence of diabetic nephropathy and recognize its role as a major contributor to end-stage kidney disease in the U.S.
    • Recognize the clinical manifestations leading to the development and stage progression of diabetic nephropathy.
    • Utilize evolving therapeutic approaches to the treatment of diabetic nephropathy, including new diabetes drugs, dialysis and kidney transplantation.
     
    Management of Diabetes in the Elderly Patient
    Upon completion of this session, participants should be better able to:
    • Recognize the importance of determining glycemic goals due to the catastrophic consequences of diabetes in the elderly population.
    • Appropriately select and use oral agents in the treatment of elderly patients with diabetes.
    • Determine when and how to start insulin therapy in elderly populations with diabetes.

    Diabetes and CV Outcomes
    Upon completion of this session, participants should be better able to:
    • Evaluate the excess risk of CVD associated with DM compared to non-diabetic patients.
    • Evaluate the evidence that the use of SGLT2 inhibitors and GLP-1 agonists in diabetic patients is associated with the reduction of CVD.
    • Describe the mechanisms of action for the reduction of CVD with SGLT2 inhibitors and GLP-1 agonists and the lack of relationship to reduction in A1C.
     
     
     


DISCLAIMER

Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult FDA-approved uses and information prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying any information provided for any professional use.
​​​​​​